Adventist Health Ukiah Valley recently unveiled its new PET/CT machine, which will offer faster results and peace of mind for ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and ...

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well ...

This article is authored by Dr Baljinder Singh, professor, Department of Nuclear Medicine, PGIMER, Chandigarh.

The rising cancer burden in Kenya has exposed critical gaps in the accessibility and affordability of cancer care. With the ...

At Midland Memorial Hospital, we understand hearing the word “radiation” can make patients nervous — and that is a valid concern. A CT scan (computer tomography scan) exposes the body to ionizing ...

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

The ongoing ARASTEP trial evaluates darolutamide plus ADT vs placebo for high-risk prostate cancer biochemical recurrence ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a prostate, testicular, and penile cancers ...

Medical imaging scans that create detailed images of the body’s internal structures are widely used in medicine. Doctors need ...

The primary end point is rPFS by PSMA PET-CT as assessed by blinded independent central review (BICR). Secondary end points include metastasis-free survival by conventional imaging by BIRC, time to ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However, clinical trials are needed to clarify the optimal clinical utility.